CORT
Corcept Therapeutics Inc
Price:  
30.04 
USD
Volume:  
1,837,328.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CORT EV/EBITDA

-55.0%
Upside

As of 2024-06-22, the EV/EBITDA ratio of Corcept Therapeutics Inc (CORT) is 24.14. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CORT's latest enterprise value is 2,977.71 mil USD. CORT's TTM EBITDA according to its financial statements is 123.35 mil USD. Dividing these 2 quantities gives us the above CORT EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 7.0x - 9.3x 8.2x
Forward P/E multiples 10.7x - 12.9x 12.2x
Fair Price 9.71 - 16.71 13.51
Upside -67.7% - -44.4% -55.0%
30.04 USD
Stock Price
13.51 USD
Fair Price

CORT EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2024-06-21 24.14
2024-06-20 23.60
2024-06-18 22.55
2024-06-17 22.92
2024-06-14 23.24
2024-06-13 25.38
2024-06-12 26.34
2024-06-11 26.46
2024-06-10 25.74
2024-06-07 26.90
2024-06-06 27.89
2024-06-05 27.85
2024-06-04 26.53
2024-06-03 25.20
2024-05-31 24.25
2024-05-30 25.13
2024-05-29 25.40
2024-05-28 25.47
2024-05-24 22.01
2024-05-23 22.28
2024-05-22 22.94
2024-05-21 23.09
2024-05-20 23.16
2024-05-17 22.49
2024-05-16 22.03
2024-05-15 22.28
2024-05-14 22.13
2024-05-13 22.02
2024-05-10 21.61
2024-05-09 21.24
2024-05-08 20.22
2024-05-07 19.45
2024-05-06 19.02
2024-05-03 19.48
2024-05-02 19.94
2024-05-01 18.94
2024-04-30 18.47
2024-04-29 18.51
2024-04-26 18.03
2024-04-25 17.53
2024-04-24 17.76
2024-04-23 18.20
2024-04-22 17.61
2024-04-19 18.16
2024-04-18 17.91
2024-04-17 18.20
2024-04-16 18.53
2024-04-15 18.33
2024-04-12 18.63
2024-04-11 18.89